Trial Profile
Economic Analyses Alongside the REDUCE Clinical Trial [700012063]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Dec 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Therapeutic Use
- Sponsors GSK
- 01 Mar 2013 New trial record